Hao-Ran Dai

8PUBLICATIONS
14CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Metabolomic chemistryInfant and child healthMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 21, 2024
Development and application of a population pharmacokinetic model repository for caffeine dose tailoring in preterm infants.

Hao-Ran Dai, Hong-Li Guo, Ya-Hui Hu

|Jun 26, 2024
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tablets.

Wei-Jun Wang, Yue Li, Ya-Hui Hu

|May 17, 2024
Trilaciclib dosage in Chinese patients with extensive-stage small cell lung cancer: a pooled pharmacometrics analysis.

Hao-Ran Dai, Yang Yang, Chen-Yu Wang

|Feb 24, 2024
Development and Evaluation of a Quantitative Systems Pharmacology Model for Mechanism Interpretation and Efficacy Prediction of Atezolizumab in Combination with Carboplatin and Nab-Paclitaxel in Patients with Non-Small-Cell Lung Cancer.

Chen-Yu Wang, Hao-Ran Dai, Yu-Ping Tan

|Jul 12, 2023
From "wet" matrices to "dry" blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants.

Hao-Ran Dai, Hong-Li Guo, Wei-Jun Wang

|Sep 30, 2022
Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration-to-dose ratio.

Yue Li, Na Dong, Yu-Xin Qin

Pageof 2

Frequent Collaborators

5 joint publications

Feng Chen

4 joint publications

Ya-Hui Hu

4 joint publications

Hong-Li Guo

3 joint publications

Zheng Jiao